Portfolio

Medical2Market BV is a company that develops medical inventions and technologies, which solve medical problems in a safe, effective and cost-efficient manner. Medical2Market brings its own products on the market and offers its competencies and infrastructure to medical inventors.  Medical2Market is ISO 13485 certified.

Stroke2prevent has developed a medical device that improves outcome of the cardiac patients. The product A-View is used to resolve the so called ‘blind-spot’ caused by interposition of the trachea in Transesophageal Echocardiography (TEE). A-View provides images of of the entire thoracic aortic arch allowing detection of atherosclerosis, diagnosing aortic diseases and to permits monitoring of vascular flow. The product is CE Certified and FDA approved.

HemoClear enables easy autologous lost blood recuperation driven by gravity only. The unique feature of the method is recuperation of not only the red blood cells, but also of the platelets. Without plasma toxins and pathological elements, the cells can be re-transfused.

​

The device HemoClear is CE Certified and already distributed in many countries.

MicroVision Medical has developed the next generation of monitoring in acute healthcare. It is the new generation of circulation monitoring. 

Their solution is high quality imaging of the micro circulation and together with their software they allow the best possible images to be analyzed.

The innovation of ResQure prevents or decreases brain injury in resuscitated cardiac arrest patients. The company has developed a priority medical solution to save the brain. The company is still in the start-up phase. 

ViCentra believes that easy-to-use product with beautiful design and outstanding results, bring more satisfaction and are more likely to help people achieve whatever they want. With the development of the product Kaleido as the next generation of closed loop diabetic pumps, they improve the life of many patients.

Improves the quality of life and life expectancy of patients with heart failure. Improving the efficacy of advanced cardiac pacemakers.